Medicine
Felopdipine 10 mg extended-release tablet
Felopdipine 10 mg extended-release tablet is a prescription medicine containing Felodipine for oral use, marketed by A-S Medication Solutions, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F). Protect from light.
Key facts
- Active ingredient (INN)
- Felodipine
- Brand
- Felopdipine
- Strength
- 10 mg
- Dosage form
- Extended-release tablet
- Route
- Oral
- Packs
- 30 tablets, 100 tablets
- Marketing authorisation holder
- A-S Medication Solutions
- Manufacturers
- A-S Medication SolutionsWestminster Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F). Protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C08CA02 Felodipine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 31 March 2023
- Identifiers
- RxCUI 402695, 402696, 402698DailyMed set ID 129c48eb-29f2-462b-ad8a-b3bf1b193115, a6560584-e39f-47b3-84db-95da1f90fd40NDC 50090-7206, 69367-266Application ANDA210847
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet, extended release in 1 bottle | 50090-7206-0 | A-S Medication Solutions | 5 August 2024 |
| 100 tablet, extended release in 1 bottle | 69367-266-01 | Westminster Pharmaceuticals | 31 March 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 25 July 1991 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Felodipine 10 mg extended-release tablet.
Other strengths and forms of Felodipine
Clinical summary
Felodipine is a dihydropyridine calcium channel blocker indicated for the treatment of hypertension, to lower blood pressure. It is available as extended-release tablets and tablets for oral use. MedsAcross supplies Felodipine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about FelodipineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- FELODIPINE prescribing information (Avet Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Felopdipine 10 mg extended-release tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.